Ilaris and Atrial fibrillation aggravated - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation aggravated is reported as a side effect among people who take Ilaris (canakinumab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Marijuana, and have Juvenile rheumatoid arthritis.

The phase IV clinical study analyzes which people have Atrial fibrillation aggravated when taking Ilaris. It is created by eHealthMe based on reports of 13,051 people who have side effects when taking Ilaris from the FDA, and is updated regularly.

What is Ilaris?

Ilaris has active ingredients of canakinumab. eHealthMe is studying from 13,059 Ilaris users. Check the latest studies of Ilaris.

What is Atrial fibrillation aggravated?

Atrial fibrillation aggravated (serious fibrillation of the muscles of the atria of the heart) is found to be associated with 2,183 drugs and 1,174 conditions by eHealthMe. Check the latest studies of Atrial fibrillation aggravated.

On Jul, 14, 2026

13,051 people reported to have side effects when taking Ilaris.
Among them, 14 people (0.11%) have Atrial fibrillation aggravated.

Could Ilaris cause Atrial fibrillation aggravated?

Among these 14 people:

How long have people been on Ilaris when they have Atrial fibrillation aggravated? *

What is the gender of people who have Atrial fibrillation aggravated when taking Ilaris? *

female: 42.86 %
male: 57.14 %

What is the age of people who have Atrial fibrillation aggravated when taking Ilaris? *

What are other drugs people take besides Ilaris? *

What are other side effects people have besides Atrial fibrillation aggravated? *

Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 21.43%
Osteomyelitis (infection of bone): 3 people, 21.43%
Pneumonia: 2 people, 14.29%
Oesophageal Infection: 2 people, 14.29%
Cardiac Failure Acute: 2 people, 14.29%
Death: 2 people, 14.29%
Sick Sinus Syndrome (a collection of heart rhythm disorders): 1 person, 7.14%
Disease Progression: 1 person, 7.14%
Bleeding Disorders: 1 person, 7.14%
Blood Glucose Increased: 1 person, 7.14%

What are the existing conditions these people have? *

Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 4 people, 28.57%
Type 2 Diabetes: 2 people, 14.29%
High Blood Pressure: 2 people, 14.29%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 14.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 14.29%
Cardiac Failure Chronic: 2 people, 14.29%
Skin Ulcer: 1 person, 7.14%
Schnitzler's Syndrome (a rare disease characterized by chronic hives (urticaria) and periodic fever, bone pain and joint pain): 1 person, 7.14%
Ischaemic Cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease): 1 person, 7.14%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ilaris and have Atrial fibrillation aggravated?

- Check whether Atrial fibrillation aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ilaris:

Ilaris (13,059 reports)

Browse all side effects of Ilaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation aggravated:

Atrial fibrillation aggravated (2,183 drugs)

Browse all the conditions that are associated with Atrial fibrillation aggravated:

Atrial fibrillation aggravated (1,174 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on canakinumab (the active ingredients of Ilaris) and Ilaris (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.